DNTH vs. NVDA

Last updated Jul 14, 2026

DNTH (Dianthus Therapeutics Inc.) and NVDA (NVIDIA Corporation) are both stocks. DNTH operates in Biotechnology (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past year, DNTH returned 391.72% vs 23.58% for NVDA. At a 0.16 correlation, their price movements are largely independent.

Performance

DNTH vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dianthus Therapeutics Inc. (DNTH) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DNTH achieves a 139.36% return, which is significantly higher than NVDA's 9.26% return.

DNTH

• 1D: 1.07%
• 1M: 20.19%
• 6M: 152.15%
• YTD: 139.36%
• 1Y: 391.72%
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVDA

• 1D: -3.52%
• 1M: -0.81%
• 6M: 10.19%
• YTD: 9.26%
• 1Y: 23.58%
• 3Y*: 64.91%
• 5Y*: 59.41%
• 10Y*: 65.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DNTH vs. NVDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
DNTH Dianthus Therapeutics Inc.	139.36%	89.04%	109.62%	0.00%
NVDA NVIDIA Corporation	9.26%	38.92%	171.25%	9.62%

Correlation

The correlation between DNTH and NVDA is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (All Time) Calculated using the full available price history since Sep 12, 2023	0.16

Fundamentals

Market Cap DNTH : $4.12B NVDA : $4.93T
EPS DNTH : -$0.45 NVDA : $6.53
PS Ratio DNTH : 2.85K NVDA : 19.64
Total Revenue (TTM) DNTH : $873.00K NVDA : $253.49B
Gross Profit (TTM) DNTH : $873.00K NVDA : $187.95B
EBITDA (TTM) DNTH : -$187.38M NVDA : $192.76B

Return for Risk

DNTH vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DNTH

DNTH Risk / Return Rank: 99
DNTH Sharpe Ratio Rank: 100
DNTH Sortino Ratio Rank: 99
DNTH Omega Ratio Rank: 98
DNTH Calmar Ratio Rank: 100
DNTH Martin Ratio Rank: 99

NVDA

NVDA Risk / Return Rank: 65
NVDA Sharpe Ratio Rank: 67
NVDA Sortino Ratio Rank: 63
NVDA Omega Ratio Rank: 60
NVDA Calmar Ratio Rank: 69
NVDA Martin Ratio Rank: 68

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DNTH vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dianthus Therapeutics Inc. (DNTH) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	DNTH	NVDA	Difference
Sharpe ratio: Return per unit of total volatility	6.06	0.66	+5.39
Sortino ratio: Return per unit of downside risk	5.38	1.14	+4.23
Omega ratio: Gain probability vs. loss probability	1.68	1.13	+0.55
Calmar ratio: Return relative to maximum drawdown	19.55	1.17	+18.38
Martin ratio: Return relative to average drawdown	49.60	2.53	+47.07

DNTH vs. NVDA - Sharpe Ratio Comparison

The current DNTH Sharpe Ratio is 6.06, which is higher than the NVDA Sharpe Ratio of 0.66. The chart below compares the historical Sharpe Ratios of DNTH and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

DNTH vs. NVDA - Drawdown Comparison

The maximum DNTH drawdown since its inception was -53.48%, smaller than the maximum NVDA drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for DNTH and NVDA.

Drawdown Indicators

	DNTH	NVDA	Difference
Max Drawdown Largest peak-to-trough decline	-53.48%	-89.72%	+36.24%
Max Drawdown (1Y) Largest decline over 1 year	-20.20%	-20.21%	+0.01%
Max Drawdown (3Y) Largest decline over 3 years	—	-36.88%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-66.34%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-66.34%	—
Current Drawdown Current decline from peak	-1.39%	-13.56%	+12.17%
Average Drawdown Average peak-to-trough decline	-17.56%	-36.12%	+18.56%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.95%	9.35%	-1.40%

Volatility

DNTH vs. NVDA - Volatility Comparison

Dianthus Therapeutics Inc. (DNTH) has a higher volatility of 15.41% compared to NVIDIA Corporation (NVDA) at 10.82%. This indicates that DNTH's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DNTH	NVDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.41%	10.82%	+4.59%
Volatility (6M) Calculated over the trailing 6-month period	46.66%	27.37%	+19.29%
Volatility (1Y) Calculated over the trailing 1-year period	65.30%	35.74%	+29.56%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	76.94%	51.87%	+25.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	76.94%	49.90%	+27.04%

Dividends

DNTH vs. NVDA - Dividend Comparison

DNTH has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.14%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DNTH Dianthus Therapeutics Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVDA NVIDIA Corporation	0.14%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%

Financials

Frequently Asked Questions

Can I hold both DNTH and NVDA in my portfolio?

DNTH and NVDA have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DNTH or NVDA?

DNTH has higher volatility (15.41%) compared to NVDA (10.82%). In terms of maximum drawdown, DNTH dropped -53.48% vs NVDA's -89.72%.

Which has better risk-adjusted returns?

DNTH currently has the higher Sharpe Ratio (6.06 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.